GNTLF (Genetic Technologies) Other Stockholders Equity : $-0.00 Mil (As of Jun. 2024)

View and export this data going back to 2002. Start your Free Trial

What is Genetic Technologies Other Stockholders Equity?

Genetic Technologies's Other Stockholders Equity for the quarter that ended in Jun. 2024 was $-0.00 Mil.

Genetic Technologies's quarterly Other Stockholders Equity stayed the same from Dec. 2023 ($0.00 Mil) to Mar. 2024 ($0.00 Mil) but then declined from Mar. 2024 ($0.00 Mil) to Jun. 2024 ($-0.00 Mil).

Genetic Technologies's annual Other Stockholders Equity increased from Jun. 2022 ($-0.00 Mil) to Jun. 2023 ($-0.00 Mil) but then declined from Jun. 2023 ($-0.00 Mil) to Jun. 2024 ($-0.00 Mil).

Genetic Technologies Other Stockholders Equity Historical Data

The historical data trend for Genetic Technologies's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetic Technologies Other Stockholders Equity Chart

Genetic Technologies Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Other Stockholders Equity

Get a 7-Day Free Trial

Genetic Technologies Quarterly Data
	Jun19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Other Stockholders Equity	Get a 7-Day Free Trial															-	-	-	-	-

Genetic Technologies Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Genetic Technologies Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Genetic Technologies's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Genetic Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetic Technologies Ltd (OTCPK:GNTLF) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

GENE:USA 0A4N:UK DU8:Germany GTG:Australia

Address

60-66 Hanover Street, Fitzroy, Melbourne, VIC, AUS, 3065

Website

https://www.gtglabs.com

Genetic Technologies Ltd is an Australia-based molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast healthcare and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the company's revenue is generated from Australia and the United States. The group has two operating segments: EasyDNA and GeneType/Corporate.